相关实验视频

Updated: May 3, 2026

Driving Under the Influence: How Music Listening Affects Driving Behaviors

Driving Under the Influence: How Music Listening Affects Driving Behaviors

Published on: March 27, 2019

50岁及以上的美国成年人吸食大麻后驾驶:简短的沟通

Erin E Bonar¹, Lianlian Lei², Matthias Kirch³

¹Department of Psychiatry, University of Michigan, 2800 Plymouth Road, Building 16, Floor 2, Ann Arbor, MI 48109, USA; Michigan Innovations in Addiction Care through Research & Education Program, Department of Psychiatry, 2800 Plymouth Road, Building 16, Floor 2, Ann Arbor, MI 48109, USA; Injury Prevention Center, University of Michigan, Building 10, Ground Floor, Ann Arbor, MI 48109, USA; Institute for Healthcare Policy and Innovation, University of Michigan, 2800 Plymouth Road, Building 16, Ann Arbor, MI 48109, USA.

Drug and alcohol dependence

|December 2, 2025

概括

大约五分之一的使用大麻的老年人 (50+) 报告在使用大麻后驾驶 (DCU). 男人,日常使用者,以及因心理健康原因使用大麻的人更有可能在使用后开车.

科学领域:

老年学是指老年学的学科.
公共卫生公共卫生
大麻研究大麻研究

背景情况:

美国成年人中大麻消费量正在上升,增加了驾驶障碍等风险.
在老年人 (50+) 中,了解大麻使用后驾驶 (DCU) 对于有针对性的预防至关重要.
这项研究研究了50岁及以上的成年人中DCU的患病率和相关性.

研究的目的:

在50岁及以上的成年人中确定大麻使用后自报告驾驶 (DCU) 的患病率.
在这个人口群体中确定与DCU相关的因素.
在老年人群中为大麻影响驾驶的预防策略的制定提供信息.

主要方法:

利用来自50岁以上3379名成年人的全国代表性研究的数据.
包括729名参与者 (21.4%),他们报告去年使用大麻.
采用后勤回归来分析社会人口统计,社会功能,照顾,大麻使用模式和DCU之间的关联.

主要成果:

20.2%的老年大麻使用者表示在使用后开车.
调整后的分析显示,男性 (OR=1.72),日常大麻使用 (OR=3.31) 和心理健康动机 (OR=1.93) 与DCU有显著的关联.
在未经调整的分析中,频繁使用和与心理健康和睡眠有关的动机与DCU有关.

结论:

大约有五分之一的50岁及以上的成年人使用大麻,在使用后参与驾驶.
防止大麻影响驾驶的干预措施应该针对这个人口群体.
临床医生可以通过考虑心理健康问题和日常使用大麻等风险因素来定制预防.

关键词:

大麻大麻大麻大麻大麻大麻大麻大麻驾驶障碍驾驶障碍是一种驾驶障碍.年龄较大的成年人.

更多相关视频

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Administration of Δ⁹-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

相关概念视频

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...